Inflammatory and Glutamatergic Homeostasis Are Involved in Successful Aging

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 71, Issue 3, 2016, Pages 281-289

  Hascup, Erin R ^a   Wang, Feiya ^a   Kopchick, John J ^b   Bartke, Andrzej ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OHIO UNIVERSITY   (United States)

Author keywords

Aging; Brain; Cognition; Glutamate; Inflammation; Insulin like growth factor

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 1; MESSENGER RNA; SLC1A3 PROTEIN, MOUSE; SOMATOMEDIN;

AGING; ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; INFLAMMATION; METABOLISM; MOUSE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

AGING; ANIMALS; EXCITATORY AMINO ACID TRANSPORTER 1; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HOMEOSTASIS; INFLAMMATION; MICE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOMATOMEDINS;

EID: 84959881102     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glv010     Document Type: Article

References (53)

1. Callaerts-Vegh Z, Moechars D, Van Acker N, et al. Haploinsufficiency of VGluT1 but not VGluT2 impairs extinction of spatial preference and response suppression. Behav Brain Res. 2013;245:13-21.
2. Haglund L, Swanson LW, Köhler C. The projection of the supramammillary nucleus to the hippocampal formation: an immunohistochemical and anterograde transport study with the lectin PHA-L in the rat. J Comp Neurol. 1984;229:171-185.
3. Kashani A, Betancur C, Giros B, Hirsch E, El Mestikawy S. Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease. Neurobiol Aging. 2007;28:568-578.
4. Kirvell SL, Esiri M, Francis PT. Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease. J Neurochem. 2006;98:939-950.
5. Nickell J, Pomerleau F, Allen J, Gerhardt GA. Age-related changes in the dynamics of potassium-evoked L-glutamate release in the striatum of Fischer 344 rats. J Neural Transm. 2005;112:87-96.
6. Stephens ML, Quintero JE, Pomerleau F, Huettl P, Gerhardt GA. Agerelated changes in glutamate release in the CA3 and dentate gyrus of the rat hippocampus. Neurobiol Aging. 2011;32:811-820.
7. Tong Q, Ye C, McCrimmon RJ, et al. Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia. Cell Metab. 2007;5:383-393.
8. Tordera RM, Totterdell S, Wojcik SM, et al. Enhanced anxiety, depressivelike behaviour and impaired recognition memory in mice with reduced expression of the vesicular glutamate transporter 1 (VGLUT1). Eur J Neurosci. 2007;25:281-290.
9. Tsamis KI, Mytilinaios DG, Njau SN, Baloyannis SJ. Glutamate receptors in human caudate nucleus in normal aging and Alzheimer's disease. Curr Alzheimer Res. 2013;10:469-475.
10. Vertes RP, McKenna JT. Collateral projections from the supramammillary nucleus to the medial septum and hippocampus. Synapse. 2000;38:281-293.
11. Villa RF, Ferrari F, Gorini A. Energy metabolism of rat cerebral cortex, hypothalamus and hypophysis during ageing. Neuroscience. 2012;227:55-66.
12. Ziegler DR, Cullinan WE, Herman JP. Distribution of vesicular glutamate transporter mRNA in rat hypothalamus. J Comp Neurol. 2002;448:217-229.
13. Hascup KN, Hascup ER. Altered neurotransmission prior to cognitive decline in AβPP/PS1 mice, a model of Alzheimer's disease. J Alzheimers Dis. 2015;44:771-776.
14. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest. 1997;99:361-365.
15. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes. 1995;44:180-184.
16. Felger JC, Miller AH. Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front Neuroendocrinol. 2012;33:315-327.
17. Fogal B, Li J, Lobner D, McCullough LD, Hewett SJ. System x©- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury. J Neurosci. 2007;27:10094-10105.
18. Gegelashvili G, Robinson MB, Trotti D, Rauen T. Regulation of glutamate transporters in health and disease. Prog Brain Res. 2001;132:267-286.
19. Maragakis NJ, Dykes-Hoberg M, Rothstein JD. Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann Neurol. 2004;55:469-477.
20. Miller AH, Haroon E, Raison CL, Felger JC. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress Anxiety. 2013;30:297-306.
21. Mitew S, Kirkcaldie MT, Dickson TC, Vickers JC. Altered synapses and gliotransmission in Alzheimer's disease and AD model mice. Neurobiol Aging. 2013;34:2341-2351.
22. Sziklas V, Petrides M. Memory and the region of the mammillary bodies. Prog Neurobiol. 1998;54:55-70.
23. Ma XC, Gottschall PE, Chen LT, Wiranowska M, Phelps CP. Role and mechanisms of interleukin-1 in the modulation of neurotoxicity. Neuroimmunomodulation. 2002;10:199-207.
24. Moraes CA, Santos G, Spohr TCL de SE, et al. Activated microglia-induced deficits in excitatory synapses through IL-1β: Implications for Cognitive Impairment in Sepsis. Mol Neurobiol. 2014. doi:10.1007/s12035-014-8868-5
25. Ramírez G, Rey S, von Bernhardi R. Proinflammatory stimuli are needed for induction of microglial cell-mediated AbetaPP-{244-C} and Abeta-neurotoxicity in hippocampal cultures. J Alzheimers Dis. 2008;15:45-59.
26. Hsiao HY, Chen YC, Chen HM, Tu PH, Chern Y. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease. Hum Mol Genet. 2013;22:1826-1842.
27. Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun. 2011;25:181-213.
28. Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther. 2003;304:1-7.
29. von Bernhardi R, Tichauer JE, Eugenín J. Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. J Neurochem. 2010;112:1099-1114.
30. Deak F, Sonntag WE. Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1. J Gerontol A Biol Sci Med Sci. 2012;67:611-625.
31. Cohen E, Paulsson JF, Blinder P, et al. Reduced IGF-1 signaling delays ageassociated proteotoxicity in mice. Cell. 2009;139:1157-1169.
32. Lorenzini A, Salmon AB, Lerner C, et al. Mice producing reduced levels of insulin-like growth factor type 1 display an increase in maximum, but not mean, life span. J Gerontol A Biol Sci Med Sci. 2014;69:410-419.
33. Bartke A, Bonkowski M, Masternak M. THow diet interacts with longevity genes. Hormones (Athens). 2008;7:17-23.
34. Masternak MM, Bartke A. Growth hormone, inflammation and aging. Pathobiol Aging Age Relat Dis. 2012;2.
35. Zhou Y, Xu BC, Maheshwari HG, et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci U S A. 1997;94:13215-13220.
36. Westbrook R, Bonkowski MS, Arum O, Strader AD, Bartke A. Metabolic alterations due to caloric restriction and every other day feeding in normal and growth hormone receptor knockout mice. J Gerontol A Biol Sci Med Sci. 2014;69:25-33.
37. Hong SL, Longo KA, Gosney E, Kopchick JJ. Increased metabolic flexibility and complexity in a long-lived growth hormone insensitive mouse model. J Gerontol A Biol Sci Med Sci. 2014;69:274-281.
38. Panici JA, Wang F, Bonkowski MS, et al. Is altered expression of hepatic insulin-related genes in growth hormone receptor knockout mice due to GH resistance or a difference in biological life spans? J Gerontol A Biol Sci Med Sci. 2009;64:1126-1133.
39. Masternak MM, Al-Regaiey KA, Del Rosario Lim MM, et al. Caloric restriction results in decreased expression of peroxisome proliferatoractivated receptor superfamily in muscle of normal and long-lived growth hormone receptor/binding protein knockout mice. J Gerontol A Biol Sci Med Sci. 2005;60:1238-1245.
40. Masser DR, Bixler GV, Brucklacher RM, et al. Hippocampal subregions exhibit both distinct and shared transcriptomic responses to aging and nonneurodegenerative cognitive decline. J Gerontol A Biol Sci Med Sci. 2014;69:1311-1324.
41. Ahn HJ, Hernandez CM, Levenson JM, Lubin FD, Liou HC, Sweatt JD. c-Rel, an NF-kappaB family transcription factor, is required for hippocampal long-term synaptic plasticity and memory formation. Learn Mem. 2008;15:539-549.
42. Kaltschmidt B, Ndiaye D, Korte M, et al. NF-kappaB regulates spatial memory formation and synaptic plasticity through protein kinase A/CREB signaling. Mol Cell Biol. 2006;26:2936-2946.
43. Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D. NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci. 2003;6:1072-1078.
44. Kaltschmidt C, Kaltschmidt B, Baeuerle PA. Brain synapses contain inducible forms of the transcription factor NF-kappa B. Mech Dev. 1993;43:135-147.
45. Suzuki T, Mitake S, Okumura-Noji K, Yang JP, Fujii T, Okamoto T. Presence of NF-kappaB-like and IkappaB-like immunoreactivities in postsynaptic densities. Neuroreport. 1997;8:2931-2935.
46. Boersma MC, Dresselhaus EC, De Biase LM, Mihalas AB, Bergles DE, Meffert MK. A requirement for nuclear factor-kappaB in developmental and plasticity-associated synaptogenesis. J Neurosci. 2011;31:5414-5425.
47. Oikawa K, Odero GL, Platt E, et al. NF-κB p50 subunit knockout impairs late LTP and alters long term memory in the mouse hippocampus. BMC Neurosci. 2012;13:45.
48. Prow NA, Irani DN. The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis. J Neurochem. 2008;105:1276-1286.
49. Bartke A, Chandrashekar V, Turyn D, et al. Effects of growth hormone overexpression and growth hormone resistance on neuroendocrine and reproductive functions in transgenic and knock-out mice. Proc Soc Exp Biol Med. 1999;222:113-123.
50. Yan H, Mitschelen M, Bixler GV, et al. Circulating IGF1 regulates hippocampal IGF1 levels and brain gene expression during adolescence. J Endocrinol. 2011;211:27-37.
51. Sun LY, Al-Regaiey K, Masternak MM, Wang J, Bartke A. Local expression of GH and IGF-1 in the hippocampus of GH-deficient long-lived mice. Neurobiol Aging. 2005;26:929-937.
52. Carro E, Nuñez A, Busiguina S, Torres-Aleman I. Circulating insulinlike growth factor I mediates effects of exercise on the brain. J Neurosci. 2000;20:2926-2933.
53. Magnusson KR, Das SR, Kronemann D, Bartke A, Patrylo PR. The effects of aging and genotype on NMDA receptor expression in growth hormone receptor knockout (GHRKO) mice. J Gerontol A Biol Sci Med Sci. 2011;66:607-619.